Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3841) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency recommends that Protelos/Osseor remain available but with further restrictions 21 Februar 2014Press releaseHumanMedicines European Medicines Agency advises on compassionate use of a new combination therapy for chronic hepatitis C 21 Februar 2014Press releaseHumanMedicines European Medicines Agency gives second positive opinion for a paediatric-use marketing authorisation 21 Februar 2014Press releaseHumanMedicines European Medicines Agency recommends restricting the use of methysergide-containing medicines 21 Februar 2014Press releaseHumanMedicines European Medicines Agency and US Food and Drug Administration strengthen collaboration in pharmacovigilance area 19 Februar 2014NewsCorporateMedicines European Medicines Agency welcomes new Head of IT Development Department 17 Februar 2014NewsCorporateMedicines Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 February 2014 14 Februar 2014Press releaseVeterinary Committee for advanced therapies – election of new chair, overview of 2013 and looking ahead 14 Februar 2014NewsHumanAdvanced therapiesInnovation Regulatory information - use of eSubmission Gateway and web client extended to new procedure types from 1 April 2014 14 Februar 2014NewsCorporate Regulatory information – EMA introduces product numbers to track medicines through pre-authorisation procedures 11 Februar 2014NewsCorporate 1 … 206 207 208 209 210 Page 210 of 385 211 212 213 214 … 385
European Medicines Agency recommends that Protelos/Osseor remain available but with further restrictions 21 Februar 2014Press releaseHumanMedicines
European Medicines Agency advises on compassionate use of a new combination therapy for chronic hepatitis C 21 Februar 2014Press releaseHumanMedicines
European Medicines Agency gives second positive opinion for a paediatric-use marketing authorisation 21 Februar 2014Press releaseHumanMedicines
European Medicines Agency recommends restricting the use of methysergide-containing medicines 21 Februar 2014Press releaseHumanMedicines
European Medicines Agency and US Food and Drug Administration strengthen collaboration in pharmacovigilance area 19 Februar 2014NewsCorporateMedicines
European Medicines Agency welcomes new Head of IT Development Department 17 Februar 2014NewsCorporateMedicines
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 February 2014 14 Februar 2014Press releaseVeterinary
Committee for advanced therapies – election of new chair, overview of 2013 and looking ahead 14 Februar 2014NewsHumanAdvanced therapiesInnovation
Regulatory information - use of eSubmission Gateway and web client extended to new procedure types from 1 April 2014 14 Februar 2014NewsCorporate
Regulatory information – EMA introduces product numbers to track medicines through pre-authorisation procedures 11 Februar 2014NewsCorporate